Information  X 
Enter a valid email address

Redx Pharma PLC Ord 1P (REDX)

Date Time Source Announcement
18 Jun 2018 7:15 am
EQS
Redx Pharma (REDX): 'Focus, Realism and Results...
04 Jun 2018 7:00 am
RNS
Directorate Update and Grant of Options
30 May 2018 7:00 am
RNS
Interim Results
15 May 2018 12:00 pm
EQS
Redx Pharma (REDX): Clinical and corporate update
25 Apr 2018 10:57 am
RNS
Share Purchase by Chairman
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
24 Apr 2018 7:00 am
RNS
Redx Appoints Senior AstraZeneca Executive as CEO
13 Apr 2018 8:19 am
RNS
Holding(s) in Company
12 Apr 2018 11:28 am
RNS
Holding(s) in Company
29 Mar 2018 7:00 am
RNS
RXC004 Clinical Trial Update
22 Mar 2018 7:00 am
RNS
Redx and Deinove sign option and licence agreement
15 Mar 2018 7:00 am
RNS
Poster Presentation at AACR Annual Meeting
06 Mar 2018 4:33 pm
RNS
Result of AGM
12 Feb 2018 10:23 am
RNS
Posting of Annual Accounts & AGM notice
06 Feb 2018 7:00 am
RNS
First Patient Dosed in Phase 1/2a Trial of RXC004
22 Jan 2018 7:00 am
RNS
Appointment of Chief Medical Officer
28 Dec 2017 11:28 am
RNS
Holding(s) in Company
27 Dec 2017 5:45 pm
RNS
Share Purchase by Directors
22 Dec 2017 7:00 am
RNS
Grant of Options
20 Dec 2017 7:00 am
RNS
Final Results for the Year Ended 30 September 2017
14 Dec 2017 3:56 pm
RNS
Holding(s) in Company
08 Dec 2017 5:04 pm
RNS
Holding(s) in Company
14 Nov 2017 11:30 am
RNS
Director/PDMR Shareholding
13 Nov 2017 7:15 am
RNS
Hardman Research: Streamlined and clean
06 Nov 2017 12:00 pm
RNS
Restoration - Restoration Redx Pharma plc
  7:00 am
RNS
Redx updates strategy and resumes shares trading
03 Nov 2017 10:00 am
RNS
Exit from Administration
27 Oct 2017 8:00 am
RNS
Update on Application to the High Court
13 Oct 2017 7:00 am
RNS
Update on Court Process
31 Aug 2017 9:00 am
RNS
Redx to present new scientific data at ESMO 2017
24 Aug 2017 9:42 am
RNS
Distribution to Unsecured Creditors
14 Aug 2017 10:05 am
RNS
Directorate Change
10 Aug 2017 8:00 am
RNS
Publication of Joint Administrators' Proposals
31 Jul 2017 7:00 am
RNS
Disposal of BTK inhibitor drug development program
23 Jun 2017 2:38 pm
RNS
MHRA approval of Clinical Trial Application
22 Jun 2017 7:00 am
RNS
Update on Suspension of Trading
24 May 2017 6:35 pm
RNS
Statement re. Suspension
  4:35 pm
RNS
Suspension - Redx Pharma plc
17 May 2017 7:00 am
RNS
Interim results for six months ended 31 March 2017
15 May 2017 7:00 am
RNS
Preclinical efficacy data presented on RXC005
04 May 2017 7:00 am
RNS
Notice of Interim Results
20 Apr 2017 11:20 am
RNS
Result of AGM
  7:00 am
RNS
Appointment of Chairman
07 Apr 2017 3:56 pm
RNS
Notice of Annual General Meeting
03 Apr 2017 7:15 am
RNS
Hardman: CARB-X - new strategic collaboration
30 Mar 2017 4:03 pm
RNS
Redx Pharma awarded US$1 million grant by CARB-X
21 Mar 2017 9:05 am
RNS
Final Results Year Ended 30 September 2016
07 Mar 2017 4:33 pm
RNS
Holding(s) in Company
03 Mar 2017 2:35 pm
RNS
Holding(s) in Company
  2:27 pm
RNS
Holding(s) in Company
  2:17 pm
RNS
Holding(s) in Company
02 Mar 2017 5:01 pm
RNS
Holding(s) in Company
  5:01 pm
RNS
Holding(s) in Company
  7:50 am
RNS
Redx presentations at AACR 2017
28 Feb 2017 10:35 am
RNS
Result of General Meeting and Issue of Equity
27 Feb 2017 5:50 pm
RNS
Result of Open Offer
10 Feb 2017 1:00 pm
RNS
Result of Placing
09 Feb 2017 7:00 am
RNS
Accelerated Book Build
08 Feb 2017 6:30 pm
RNS
Accelerated Book Build
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t